Louis W. Sullivan, Director at Emergent BioSolutions Inc. (EBS), sold 56,836 shares at $111.22 ($6.3M) on 2020-09-02, disclosed to the SEC on 2020-09-04.
Open-market sale of $6.3M EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.22 | 20,525 | $2.3M | 36.1% |
| 2 | $111.22 | 20,525 | $2.3M | 36.1% |
| 3 | $111.23 | 7,893 | $878K | 13.9% |
| 4 | $111.23 | 7,893 | $878K | 13.9% |
| Total | $111.22 avg | 56,836 | $6.3M | 100% |
| Filing → |
| UTHR | SELL | 2024-05-06 | $2.7M | — | Filing → |
| UTHR | SELL | 2023-03-02 | $172K | — | Filing → |
| UTHR | SELL | 2023-02-02 | $183K | — | Filing → |